ESC 365 - Protease inhibitors and risk for heart failure among patients with human immunodeficiency virus infection

HFA Premium Access

Protease inhibitors and risk for heart failure among patients with human immunodeficiency virus infection

Session: Heart failure is a complex syndrome: look at comorbidities

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Doctor R. Jacob (Stony Brook, US)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Robin Jacob

Stony Brook University Hospital, Stony Brook (United States of America)

0 follower

4 more presentations in this session

Moderate alcohol consumption is associated with progression of left ventricular dysfunction in a European stage B heart failure population.

Speaker: Doctor B. Wong (Dublin, IE)

Long-term risk of mortality and heart failure hospitalization in patients with heart failure with and without autoimmune disease

Speaker: Ms G. Sun (Copenhagen, DK)

Chronic heart failure in real-world setting: fitting the patient into the profile

Speaker: Mr S. Radhoe (Rotterdam, NL)

Impact of diabetes on the incidence of cardiorenal syndromes and on subsequent clinical outcomes.

Speaker: Professor L. Fauchier (Tours, FR)

Access the full session

Heart failure is a complex syndrome: look at comorbidities

Speakers: Doctor R. Jacob, Doctor B. Wong, Ms G. Sun, Mr S. Radhoe, Professor L. Fauchier

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources